Related Experiment Video
Updated: Jan 2, 2026
11:57
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
Published on: July 23, 2017
10.6K
Islet Transplantation - The Canadian Perspective
1Clinical Islet Transplant Program, University of Alberta, Edmonton, Canada.
Cellr4-- Repair, Replacement, Regeneration, & Reprogramming
|December 13, 2019
Summary
Islet transplantation has evolved significantly in Canada over 20 years. Expanding this life-changing therapy to other countries, particularly the US, presents both challenges and opportunities for improved diabetes management.
Area of Science:
- Endocrinology
- Transplantation Medicine
- Immunology
Background:
- Islet transplantation offers a potential cure for type 1 diabetes.
- Significant advancements have been made in Canada over the last two decades.
- Widespread adoption faces hurdles in accessibility and infrastructure.
Purpose of the Study:
- To review the progress of islet transplantation in Canada.
- To identify challenges and opportunities for international expansion.
- To inform strategies for broader therapeutic availability, especially in the US.
Main Methods:
- This is a commentary, not an experimental study.
- It involves a review of the evolution of islet transplantation in Canada.
- Discussion of current challenges and future opportunities.
Main Results:
- Islet transplantation in Canada has progressed over 20 years.
- Challenges include donor availability, immunosuppression protocols, and cost.
- Opportunities lie in improved techniques, international collaboration, and policy changes.
Conclusions:
- Continued innovation is crucial for advancing islet transplantation.
- Addressing challenges can facilitate wider access to this therapy.
- International collaboration, especially with the US, can accelerate progress.
